These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 33650732

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.
    Batlle J, Gómez E, Rendal E, Torea J, Lourés E, Couselo M, Vila P, Sedano C, Tusell X, Magallón M, Quintana M, González-Boullosa R, López-Fernández MF.
    Ann Hematol; 1996 May; 72(5):321-6. PubMed ID: 8645745
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR, Brown S, Collins PW, Keeling DM, Liesner R.
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [Abstract] [Full Text] [Related]

  • 47. Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience.
    Peerschke EI, Castellone DD, Ledford-Kraemer M, Van Cott EM, Meijer P, NASCOLA Proficiency Testing Committee.
    Am J Clin Pathol; 2009 Apr; 131(4):552-8. PubMed ID: 19289591
    [Abstract] [Full Text] [Related]

  • 48. Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.
    Kitchen S, Jennings I, Makris M, Kitchen DP, Woods TA, Walker ID.
    Haemophilia; 2016 Sep; 22(5):806-12. PubMed ID: 27217329
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Two-center validation of assays for the detection of binding and neutralizing anti-factor VIII antibodies.
    Müller J, Neimanis S, Kahle J, Albert T, Schultze Strasser S, Rup B, Pötzsch B, Königs C, Oldenburg J, ABIRISK ConsortiumInstitute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany..
    Haemophilia; 2024 Jan; 30(1):224-231. PubMed ID: 37824540
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Variation in inhibitor reactivity in acquired haemophilia A with different concentrates.
    Sukhu K, Keeling DM, Giangrande PL.
    Clin Lab Haematol; 2000 Oct; 22(5):287-90. PubMed ID: 11122270
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.
    Holstein K, Marx G, Lentz B, Bokemeyer C, Langer F.
    Hamostaseologie; 2012 Oct; 32 Suppl 1():S48-51. PubMed ID: 22960877
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P, Plamenová I, Hollý P, Stasko J.
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [Abstract] [Full Text] [Related]

  • 59. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E, Collecutt M, Street A.
    Methods Mol Biol; 2013 Jun; 992():321-33. PubMed ID: 23546724
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.